- Home
- MRC vs NKTR Comparison
MRC vs NKTR Comparison
Compare MRC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRC
- NKTR
- Stock Information
- Founded
- MRC 1921
- NKTR 1990
- Country
- MRC United States
- NKTR United States
- Employees
- MRC N/A
- NKTR N/A
- Industry
- MRC Industrial Machinery/Components
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- MRC Industrials
- NKTR Health Care
- Exchange
- MRC Nasdaq
- NKTR Nasdaq
- Market Cap
- MRC 1.1B
- NKTR 1.2B
- IPO Year
- MRC 2012
- NKTR 1994
- Fundamental
- Price
- MRC $13.98
- NKTR $60.92
- Analyst Decision
- MRC Buy
- NKTR Strong Buy
- Analyst Count
- MRC 3
- NKTR 6
- Target Price
- MRC $15.67
- NKTR $91.67
- AVG Volume (30 Days)
- MRC 542.1K
- NKTR 877.0K
- Earning Date
- MRC 11-06-2025
- NKTR 11-06-2025
- Dividend Yield
- MRC N/A
- NKTR N/A
- EPS Growth
- MRC N/A
- NKTR N/A
- EPS
- MRC N/A
- NKTR N/A
- Revenue
- MRC $2,945,000,000.00
- NKTR $74,934,000.00
- Revenue This Year
- MRC $5.81
- NKTR N/A
- Revenue Next Year
- MRC $5.43
- NKTR N/A
- P/E Ratio
- MRC N/A
- NKTR N/A
- Revenue Growth
- MRC N/A
- NKTR N/A
- 52 Week Low
- MRC $9.23
- NKTR $6.48
- 52 Week High
- MRC $15.59
- NKTR $65.79
- Technical
- Relative Strength Index (RSI)
- MRC 48.45
- NKTR 57.87
- Support Level
- MRC $13.14
- NKTR $59.23
- Resistance Level
- MRC $14.55
- NKTR $65.79
- Average True Range (ATR)
- MRC 0.43
- NKTR 4.34
- MACD
- MRC 0.06
- NKTR -0.36
- Stochastic Oscillator
- MRC 52.43
- NKTR 62.19
About MRC MRC Global Inc.
MRC Global Inc distributes pipes, valves, fittings, and other infrastructure products and services to diversified gas utility, energy, and industrial end-markets. It provides supply chain solutions, technical product service and a digital platform for customers globally. It offers a range of PVF, oilfield supply, valve automation and modification, measurement, instrumentation, and other general and specialty products. Its geographical segments include the United States and International. It generates the majority of its revenue from the United States.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.